SBFM News and Press, Sunshine Biopharma Inc. From 04/25/22

What to Know About Buying Penny Stocks on April 25th With another day of trading penny stocks here, there is a lot for investors to consider. Now, with so much going on in the stock market in the past few months, investors should be used to a high level of volatility. [Read More] ...

ERYTECH Pharma (ERYP) +53% divests US manufacturing facility for $44.5M and enters long-term supply pact with Catalent. Nkarta (NKTX) +48% announces positive preliminary dose finding data for two lead engineered natural killer cell programs. Cango (CANG) +22% announce...

Palm Beach, FL – April 25, 2022 – FinancialNewsMedia.com News Commentary – The formation of mutational cells or tissues in female reproductive organs called ovaries leads to ovarian cancer. Cancer remains undetected until the mutation spreads to the stomach ...

MONTREAL, April 25, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has filed a provisiona...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sunshine Biopharma ( SBFM ) stock spiked recently due to exciting anti-cancer-drug test results. However, some investors may be deterred from buying the stock in the wake of a particular filing from the company. ...

Sunshine Biopharma is developing novel Topoisomerase II inhibiting cancer therapies and PLpro inhibiting antiviral drugs. The Company has a strong IP backing, although much of it is tied in with the CEO. The Company recently raised $13.6 million in net proceeds from a public offer...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, many of the top trending stocks are part of two distinct categories. Big news out of the pharmaceutical sector has several microcap biotech stocks in the green. Last week, Sunshine Biopharma  (NASDAQ: SBFM ...

Gainers: Lixte Biotechnology Holdings (LIXT) +205%. PolarityTE (PTE) +96%. Biodesix (BDSX) +29%. MiNK Therapeutics (INKT) +27%. Enservco (ENSV) +25%. Actinium Pharmaceuticals (ATNM) +21%. Compass Therapeutics (CMPX) +21%. Sunshine Biopharma (SBFM) +22%. Singularity Future Technology (SGLY) +2...

Gainers: Veru (VERU) +196%. Hoth Therapeutics (HOTH) +126%. Altamira Therapeutics (CYTO) +54%. Iveda Solutions (IVDA) +37%. VNET Group (VNET) +30%. SailPoint Technologies Holdings (SAIL) +29%. Castor Maritime (CTRM) +25%. Datto Holding (MSP) +21%. Axcella Health (AXLA) +16%. TScan Therapeutic...

The shares of development-stage biotech Sunshine Biopharma (NASDAQ:SBFM) recorded the worst intraday decline in more than two years on Friday after recording three consecutive sessions of gains on the back of positive lab data on the anticancer effect of the company’s mRNA molecul...